Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Digi-Moms: Studying blood sugar levels and physical activity patterns in individuals with gestational diabetes

    In this study, we plan to conduct a prospective exploratory study in 40 participants with gestational diabetes to examine the feasibility of collecting data with ...

    View Details

  • A Phase 1b/2 Randomized Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

    The goal of the study is to find out if a new drug called LBL-007, given in combination with other drugs called tislelizumab, bevacizumab, and ...

    View Details

  • EVALUATION OF FREQUENCY ALLOCATION TABLES FOR RECENTLY IMPLANTED SINGLE-SIDED DEAF COCHLEAR IMPLANT USERS

    This observational study will examine cochlear implant (CI) patients with single-sided deafness (SSD) who receive non-default frequency allocation tables (FATs) after initial stimulation to determine ...

    View Details

  • The effects of Gender-Affirming Hormone Therapy on ambulatory blood pressure of transgender adolescents

    The goal of this study is to inform regarding effects of GAHT on blood pressure, to help improve clinical practice guidelines regarding screening and treatment ...

    View Details

  • Investigating the Temperature Dependence of Age-related Tau Pathology Relevant to Early Alzheimer's Disease

    The purpose of this study is to assess how day to day patterns in how your body temperature naturally varies over time may contribute to ...

    View Details

  • A Phase 1b Multicenter Study to Determine the Dose Safety Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.

    The purpose of the study is to evaluateTRK-950 in combination with 1) FOLFIRI or 2) Gemcitabine / Cisplatin or 3) Gemcitabine / Carboplatin or 4) Ramucirumab/Paclitaxel ...

    View Details

  • A randomized parallel-group double-blind placebo-controlled multicenter Phase III trial to investigate the efficacy and safety of secukinumab 300 mg administered subcutaneously versus placebo both in combination with a glucocorticoid taper regimen i

    The purpose of this research study is to demonstrate if secukinumab 300 mg and secukinumab 150 mg administered as an injection under the skin is ...

    View Details

  • Primary Ciliary Dyskinesia Foundation (PCDF) Clinical Registry

    Primary ciliary dyskinesia (PCD) is a disease that results in chronic cough and recurrent respiratory and sinus infections, among other symptoms. PCD is caused by ...

    View Details